Elucidation of inhibitor-binding pockets of D-amino acid oxidase using docking simulation and N-sulfanylethylanilide-based labeling technology

被引:11
作者
Kohiki, Taiki [1 ,2 ]
Kato, Yusuke [3 ]
Nishikawa, Yusuke [1 ,2 ]
Yorita, Kazuko [3 ]
Sagawa, Ikuko [4 ]
Denda, Masaya [1 ,2 ]
Inokuma, Tsubasa [1 ,2 ]
Shigenaga, Akira [1 ,2 ,5 ]
Fukui, Kiyoshi [3 ]
Otaka, Akira [1 ,2 ]
机构
[1] Tokushima Univ, Inst Biomed Sci, Tokushima 7708505, Japan
[2] Tokushima Univ, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan
[3] Tokushima Univ, Div Enzyme Pathophysiol, Inst Enzyme Res KOSOKEN, 3-18-15 Kuramoto, Tokushima 7708503, Japan
[4] Tokushima Univ, Inst Biomed Sci, Support Ctr Adv Med Sci, Grad Sch, Tokushima 7708505, Japan
[5] Japan Sci & Technol Agcy JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan
基金
日本学术振兴会;
关键词
D-ASPARTATE RECEPTOR; D-SERINE; SCHIZOPHRENIA; DISCOVERY; TARGET; DAAO; PEPTIDE; PROTEIN; UPDATE; BRAIN;
D O I
10.1039/c7ob00633k
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Because of the relevance of D-serine (D-Ser) to schizophrenia, inhibitors of D-amino acid oxidase (DAO), which catalyzes degradation of D-Ser in the presence of flavin adenine dinucleotide (FAD), are expected to be anti-schizophrenia therapeutics. In this study, binding pockets of DAO to its inhibitor 4-bromo-3-nitrobenzoic acid were searched by combining in silico docking simulation and labeling experiments employing an N-sulfanylethylanilide-based labeling technology that we have developed. The results clearly demonstrated that there are two binding pockets: one is shared with D-Ser and FAD, and the other is an unexpected cleft between the subunits of a DAO dimer. These findings will provide insight to aid the development of new DAO inhibitors. In addition, it was also proved that our labeling technology could be applicable to elucidate the binding pockets of proteins.
引用
收藏
页码:5289 / 5297
页数:9
相关论文
共 47 条
  • [1] The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia
    Abou El-Magd, R. M.
    Park, H. K.
    Kawazoe, T.
    Iwana, S.
    Ono, K.
    Chung, S. P.
    Miyano, M.
    Yorita, K.
    Sakai, T.
    Fukui, K.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (07) : 1055 - 1067
  • [2] Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia
    Boks, M. P. M.
    Rietkerk, T.
    van de Beek, M. H.
    Sommer, I. E.
    de Koning, T. J.
    Kahn, R. S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (09) : 567 - 572
  • [3] D-amino acid oxidase activity and expression are increased in schizophrenia
    Burnet, P. W. J.
    Eastwood, S. L.
    Bristow, G. C.
    Godlewska, B. R.
    Sikka, P.
    Walker, M.
    Harrison, P. J.
    [J]. MOLECULAR PSYCHIATRY, 2008, 13 (07) : 658 - 660
  • [4] Labelling of endogenous target protein via N-S acyl transfer-mediated activation of N-sulfanylethylanilide
    Denda, Masaya
    Morisaki, Takuya
    Kohiki, Taiki
    Yamamoto, Jun
    Sato, Kohei
    Sagawa, Ikuko
    Inokuma, Tsubasa
    Sato, Youichi
    Yamauchi, Aiko
    Shigenaga, Akira
    Otaka, Akira
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (26) : 6244 - 6251
  • [5] Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1H)-one Series of Potent D-Amino Acid Oxidase (DAAO) Inhibitors
    Duplantier, Allen J.
    Becker, Stacey L.
    Bohanon, Michael J.
    Borzilleri, Kris A.
    Chrunyk, Boris A.
    Downs, James T.
    Hu, Lain-Yen
    El-Kattan, Ayman
    James, Larry C.
    Liu, Shenping
    Lu, Jiemin
    Maklad, Noha
    Mansour, Mahmoud N.
    Mente, Scot
    Piotrowski, Mary A.
    Sakya, Subas M.
    Sheehan, Susan
    Steyn, Stefanus J.
    Strick, Christine A.
    Williams, Victoria A.
    Zhang, Lei
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (11) : 3576 - 3585
  • [6] Ferraris DV, 2011, CURR PHARM DESIGN, V17, P103
  • [7] Gao Y., 2001, PCT Int. Appl, Patent No. 2001070737
  • [8] A SURVEY OF HAMMETT SUBSTITUENT CONSTANTS AND RESONANCE AND FIELD PARAMETERS
    HANSCH, C
    LEO, A
    TAFT, RW
    [J]. CHEMICAL REVIEWS, 1991, 91 (02) : 165 - 195
  • [9] Free D-aspartate and D-serine in the mammalian brain and periphery
    Hashimoto, A
    Oka, T
    [J]. PROGRESS IN NEUROBIOLOGY, 1997, 52 (04) : 325 - 353
  • [10] ENDOGENOUS D-SERINE IN RAT-BRAIN - N-METHYL-D-ASPARTATE RECEPTOR-RELATED DISTRIBUTION AND AGING
    HASHIMOTO, A
    NISHIKAWA, T
    OKA, T
    TAKAHASHI, K
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 60 (02) : 783 - 786